Can we buy Gland Pharma share?
Table of Contents
On Gland Pharma shares Singhal said that the pharma counter is poised to go upside and one can buy Gland Pharma stocks at ₹2,500 to ₹2,550 levels for the immediate target of ₹2,970. He said that if an investor has time-frame of one month, then he or she can hold Gland Pharma shares for ₹3,120.
What is the target price for Gland Pharma?
with a target price of Rs 5000 for a investment time horizon of 12 months. The current market price of Gland Pharma is Rs 3637.45. Gland Pharma Ltd., incorporated in the year 1978, is a Small-Cap company (with a market cap of Rs 59897.30 Crore) operating in Pharmaceuticals sector.
Is Gland Pharma overvalued?
PB vs Industry: 543245 is overvalued based on its PB Ratio (9.1x) compared to the IN Pharmaceuticals industry average (2.8x)….Price to Book Ratio.
| PB Ratio | |
|---|---|
| industry | 2.9x |
| market | 1.6x |
Analysts say that positive sentiment related to pharma stocks has led to a strong uptrend in Gland Pharma. Gland Pharma reported revenue from operation at Rs 1,153 crore up by 31 per cent as compared to Rs 884.2 crore in the corresponding quarter of the previous fiscal.
Who is the owner of Gland Pharma?
Fosun Pharma Industrial Pte. Ltd.Gland Pharma / Parent organization
Is Gland Pharma A Chinese company?
New Delhi: Hyderabad-based pharma company Gland Pharma, owned by China’s Fosun Pharma, is the first Chinese-owned pharma company seeking to raise Rs 6,480 crore from the primary markets through an initial public offer that opens today (November 9) and will close on November 11.
Detailed Overview of the Best Pharma Stocks to Buy in India
| Sr. No. | Company Name | Return on Equity (\%) |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 10.00\% |
| 2 | Dr. Reddys Laboratories Ltd. | 13.60\% |
| 3 | Divis Laboratories Ltd. | 19.20\% |
| 4 | Cipla Ltd. | 9.17\% |
Is Gland Pharma A MNC?
Work culture is excellent, friendly nature, as MNC Company But maintain Local Standards for Employees, Excellent GMP Pharma Company But Low of Increments.